Skip to main content
. Author manuscript; available in PMC: 2014 Jan 29.
Published in final edited form as: Antivir Ther. 2012;17(1):91–100. doi: 10.3851/IMP1916

Table 3.

Inflammatory markers according to the baseline CD4 counts in the HIV-infected patients enrolled in the metabolic sub-study of the ANRS COPANA cohort.

CD4 counts at baseline (/mm3)
≤200 ]200–350] ]350–500] > 500 p
Markers N=42 N=43 N=60 N=69
hsCRP (mg/L) 2.5 [0.6–8.2] 1.2 [0.5–2.4] 1.1 [0.6–2.1] 1.2 [0.6–3.7] 0.15
MCP-1 (ng/L) 210.8 [160.9–359.4] 183.3 [112.6–308.6] 262.3 [158.7–347.8] 181.3 [126.8–325.0] 0.14
TNFα (ng/L) 8.2 [6.6–12.7] 5.6 [4.0–8.7] 7.3 [4.8–9.5] 5.0 [3.7–7.3] <0.001
sTNFR1 (ug/L) 2.1 [1.5–2.9] 1.7 [1.4–2.1] 1.7 [1.2–1.9] 1.6 [1.2–2.0] 0.03
sTNFR2 (ug/L) 3.2 [2.2 –4.1] 2.7 [2.2–3.1] 2.5 [2.0 –3.2] 2.6 [1.6 –2.9] 0.008
IL-6 (ng/L) 4.5 [2.1–9.5] 2.2 [1.2–3.7] 2.9 [1.0–4.0] 2.1 [0.8–4.6] 0.007

Data are medians and 25th to 75th percentiles [IQR], or frequencies (%). Significance was determined with the Kruskal-Wallis test.